EMBARGOED FOR RELEASE UNTIL 10 AM ET, August 19, 2019
Neurology® Journal Announces New Editor-in-Chief
José G. Merino, MD, MPhil, FAHA, FAAN, to succeed Robert A. Gross, MD, PhD, FAAN, who will complete his ten-year term in April 2020
MINNEAPOLIS 鈥 The 好色先生 (AAN) has named a new Editor-in-Chief of its medical journal , the world鈥檚 leading clinical neurology journal. Jos茅 G. Merino, MD, MPhil, FAHA, FAAN, Associate Professor, Department of Neurology, at the University of Maryland School of Medicine, will officially succeed Editor-in-Chief Robert A. Gross, MD, PhD, FAAN, who will complete his ten-year term in April 2020. Merino, who is a Fellow of the , becomes the seventh editor-in-chief of Neurology since the journal first published in 1951 and will serve a 10-year term, beginning in April 2020. 鈥淚t is my great honor to lead Neurology into the next decade as the premier journal for clinical neurologists,鈥 said Merino. 鈥淢y goal is for Neurology to remain at the forefront in disseminating cutting-edge, peer-reviewed information to the neurology community worldwide, and ultimately leading to improved care for the one in six people worldwide who are affected by neurologic disease.鈥 Neurology, the flagship journal of the AAN, is the world鈥檚 most widely read and highly cited peer-reviewed clinical neurology journal and receives over 5,000 manuscript submissions annually. Published 48 times per year, the medical journal's purpose is to advance the field of neurology by presenting new basic and clinical research with emphasis on knowledge that will influence the way neurology is practiced. In addition to Neurology, there are also three subspecialty journals the editor-in-chief oversees. Merino received his medical degree from Universidad An谩huac, Mexico and a Master of Philosophy degree from the University of Cambridge in England. He completed his residency at the Albert Einstein College of Medicine and a fellowship at the University of Western Ontario. He has taught fellows, residents and medical students and participated in clinical research programs at the Section of Stroke Diagnosis and Therapeutics of NINDS, Johns Hopkins Medicine and the University of Maryland. He was named U.S. Research Editor of The BMJ in 2012 and will step down from that position at the end of September to start the transition into his new role as editor-in-chief of Neurology.